Public procurement notice: Voluntary Ex Ante Transparency Notice
Published: 2022-12-14
Buyer: SYKEHUSINNKJØP HF
Country: NO
Contract type: Supplies
Procedure: Contract award without prior publication
CPV classification: 33000000 | 38000000
Estimated value: 31540000 NOK
Award criteria: The most economic tender

Technical requirements: Bergen Hospital Trust intends to enter into a contract with Triolab AB for the delivery of equipment for mapping structural genomic abnormalities. The instrument must fulfil certain criteria, as mentioned in the notice, and only the instruments from Triolab can fulfil this need. A procurement contract and a framework agreement will be entered into for instrument-dependent consumables with a duration lasting as long as the instruments are in use. The contract includes an extra instrument as an option, with the accompanying service and consumables,
Bergen Hospital Trust intends to enter into a contract with Triolab AB for the delivery of equipment for mapping structural genomic abnormalities. The instrument must fulfil certain criteria, as mentioned below, and only the instruments from Triolab can fulfil this need. A procurement contract and a framework agreement will be entered into for instrument-dependent consumables with a duration lasting as long as the instruments are in use. The contract includes an extra instrument as an option, with the accompanying service and consumables,
The contracting authority has performed a market analysis in the case, ref. Doffin ID: 2022-342181 and TED ID: 2022/S 125-357208. The analysis supports that there is only one current Tenderer in this procurement.
- The equipment must be able to detect different types of genomic abnormalities (insertions, deletions, balanced, and unbalanced translocations, inversions, duplications, homozygosity areas, and copy number variation).
Based on the mentioned justifications, the Contracting Authority believes that there is a legal basis to enter into a contract for equipment for mapping structural genomic deviations and accompanying instrument-dependent consumables with Triolab AB without announcing a contest, cf. the Public Procurement Regulations § 21-5, c.f. § 13-4 first paragraph, letter b, point 2.
Bergen Hospital Trust intends to enter into a contract with Triolab AB for the delivery of equipment for mapping structural genomic abnormalities. The instrument must fulfil certain criteria, as mentioned below, and only the instruments from Triolab can fulfil this need. A procurement contract and a framework agreement will be entered into for instrument-dependent consumables with a duration lasting as long as the instruments are in use. The contract includes an extra instrument as an option, with the accompanying service and consumables, The contracting authority has performed a market analysis in the case, ref. Doffin ID: 2022-342181 and TED ID: 2022/S 125-357208. The analysis supports that there is only one current Tenderer in this procurement. The equipment must fulfil the following requirements: -The equipment must be able to carry out fully genomic analyses. - The equipment must be able to detect different types of genomic abnormalities (insertions, deletions, balanced, and unbalanced translocations, inversions, duplications, homozygosity areas, and copy number variation). - The equipment must be able to detect mosaic deviations down to a fraction of minimum 5%. - The offered system must include both instrumentation and the necessary software. Based on the mentioned justifications, the Contracting Authority believes that there is a legal basis to enter into a contract for equipment for mapping structural genomic deviations and accompanying instrument-dependent consumables with Triolab AB without announcing a contest, cf. the Public Procurement Regulations § 21-5, c.f. § 13-4 first paragraph, letter b, point 2. Any enquiries about the matter must be sent via the communication module in the Mercell portal. The contract will be signed at the earliest ten days after the date of this notice.
Equipment for mapping structural genomic deviations with the accompanying instrument-dependent consumables.


Winner: Triolab AB
Award value: 31540000